Druckenmiller Dumped META and Bet $247M on Brazil With Leveraged Calls: Inside Duquesne's $4.5B Q4 2025 Macro Rotation

Stanley Druckenmiller just executed the most talked-about macro rotation of the Q4 2025 filing season. Duquesne Family Office's 13F, filed February 17, 2026, reveals that Druckenmiller completely exited Meta Platforms, re-entered Brazil (EWZ) with both shares and leveraged call options after exiting it just one quarter earlier, and deployed over $900M into new macro ETF positions — all while growing AUM to $4.49B (+10.6% QoQ). The EWZ bet has already gained 19% YTD as R$33 billion flooded into Brazil's B3 exchange in January 2026.

TL;DR

• AUM: $4.49B — up $432M (+10.6%) QoQ, a new post-2021 high for Duquesne.
• META exit: Fully liquidated after holding for only one quarter (initiated Q3 2025).
• Brazil boomerang: Exited EWZ in Q3, re-entered in Q4 with $247M in shares + calls. Already +19% YTD.
• Macro ETF blitz: $914M deployed into XLF ($301M), EWZ ($247M), RSP ($225M), SPY calls ($61M), IWM calls ($56M), and GS ($24M).
• GOOGL +277%: Tripled Alphabet stake to $121M while exiting META — selective big tech, not blanket tech exit.
• Healthcare anchor: NTRA remains #1 at $575M (12.8%), but INSM and TEVA weights halved as macro sleeve expanded.
• Airlines triple: New positions in DAL ($45M), UAL ($39M), and AAL ($10M) — a cyclical recovery bet.
• Turnover: 43.1% — classic Druckenmiller velocity.

Filing Snapshot

Duquesne Family Office LLC (CIK 0001536411) filed its Q4 2025 13F on 2026-02-17, reporting 62 line items across 60 unique holdings with a total value of $4.49B. The prior quarter (Q3 2025) showed $4.06B across 65 holdings. The +$432M increase brings Duquesne to its highest AUM since Q1 2024's $4.39B.

What makes this filing remarkable is not the size — it is the direction. In Q3, Druckenmiller rotated aggressively into healthcare, building NTRA, INSM, and TEVA into a 30%+ cluster while adding new positions in Amazon, Meta, and Alphabet. In Q4, he kept the healthcare anchor but bolted an entirely new macro sleeve onto the portfolio — financials, Brazil, equal-weight, and index options. This is a two-layer portfolio now: healthcare conviction plus macro overlay.

The Brazil Boomerang: From Zero to $247M With Calls

The most striking trade in this filing is the EWZ position. Druckenmiller exited Brazil entirely in Q3 2025, then re-entered in Q4 with 3.55 million shares plus call options — a combined position worth $247M (5.5% of portfolio). This is not a tentative toe-dip. The call options signal Druckenmiller expects a large upward move, not just modest appreciation.

The timing was impeccable. In January 2026, foreign investors poured R$33 billion into Brazil's B3 exchange — the largest monthly inflow on record. EWZ has gained 19% YTD in 2026, following a 49% gain in 2025. Three structural catalysts drove the trade:

• Selic rate cycle: Brazil's central bank began cutting rates from 13.75%, triggering domestic equity re-rating. Historically, the Ibovespa has risen in every Selic cutting cycle since 2005.
• Commodity supercycle alignment: Petrobras and Vale — the two heavyweights in EWZ — benefit from elevated oil and iron ore prices. Brazil's projected $70B trade surplus for 2026 is commodity-driven.
• Weakening USD: A declining dollar mechanically lifts EM asset returns for USD-denominated investors. This is the macro backdrop Druckenmiller reads better than almost anyone alive.

Notably, Duquesne's Brazil exposure extends beyond EWZ. The portfolio also holds MercadoLibre (MELI) at $95M (2.1%) — LatAm's dominant e-commerce and fintech platform — and BBB Foods at $89M (2.0%), a Mexican discount grocery chain. Add in YPF (Argentina) at $22M, and total LatAm exposure exceeds $500M (~11% of portfolio).

The $914M Macro ETF Blitz

Beyond Brazil, Druckenmiller deployed capital across a coordinated set of macro instruments that, taken together, read as a single thesis: the US economy broadens, financials lead, and mega-cap concentration unwinds.

Position	Value	Weight	Signal
XLF (Financial Select Sector SPDR)	$301M	6.7%	NEW — Financials outperformance bet
EWZ (iShares MSCI Brazil ETF)	$247M	5.5%	NEW — Shares + calls (leveraged EM)
RSP (Invesco S&P 500 Equal Weight)	$225M	5.0%	NEW — Anti-concentration / breadth bet
SPY calls	$61M	1.4%	Leveraged US index upside
IWM calls	$56M	1.2%	Small-cap recovery thesis
GS (Goldman Sachs)	$24M	0.5%	NEW — Direct financials equity

The XLF position at $301M is Duquesne's second-largest holding. This is a direct bet on rate-environment normalization benefiting banks, insurers, and capital markets firms. The RSP (equal-weight S&P 500) position at $225M is an anti-Magnificent-7 trade — it benefits precisely when market breadth expands and the cap-weighted index's concentration premium deflates.

The options overlay (SPY calls + IWM calls + EWZ calls) adds ~$170M of leveraged upside exposure. Druckenmiller is not hedging — he is pressing. All three options positions are calls, not puts. This is a portfolio that is net long risk with conviction.

META Exit and Selective Big Tech

Druckenmiller completely exited Meta Platforms in Q4 after initiating the position just one quarter earlier in Q3 2025. He also exited ARM Holdings, Sandisk, and Seagate Technology. This looks like a decisive rejection of the crowded mega-cap AI trade.

But it is not a blanket tech exit. Simultaneously, he increased Alphabet by 277% to $121M and grew Amazon by 69% to $193M (adding call options for leveraged upside). The distinction matters:

• Alphabet (GOOGL): Was trading at ~18x forward earnings in Q4 — the cheapest mega-cap AI exposure available. Cloud revenue accelerating, Waymo scaling, and AI search integration expanding TAM.
• Amazon (AMZN): AWS AI services revenue growing 40%+ YoY. Druckenmiller added calls on top of shares — the same leveraged conviction structure he used for EWZ.
• Meta (META): $500B+ market cap with ongoing Reality Labs cash burn. Druckenmiller's read: consensus positioning caught up to the trade.

This is classic Druckenmiller pattern recognition: buy the dislocation, ride the re-rating, exit when consensus catches up. META went from “under-owned contrarian play” to “consensus overweight” in a single quarter — exactly when he leaves.

Healthcare: Still the Anchor, But De-Concentrated

Healthcare remains Duquesne's single largest sector at approximately 29% of the portfolio, down from ~38.5% in Q3 2025. The core trio is intact:

• Natera (NTRA): $575M (12.8%) — still the #1 position by a wide margin. Natera reported ~$660M in Q4 revenue (+39% YoY) with its Signatera oncology MRD test volume growing 55% YoY. This is a legitimate platform company, not a speculative biotech.
• Insmed (INSM): $258M (5.7%) — down from ~8.7% weight in Q3. Brensocatib approval catalyst remains ahead.
• Teva (TEVA): $183M (4.1%) — down from ~8.4% weight in Q3. Generic pharma turnaround thesis maturing.

The weight reduction in INSM and TEVA is partly mechanical — the new macro ETF sleeve diluted all existing positions. But the healthcare overweight remains substantial. Druckenmiller is running a barbell: one massive conviction bet (NTRA) plus a diversified tail of clinical-stage names including NewAmsterdam Pharma ($108M), Cogent Biosciences ($79M), Option Care Health ($56M), and several sub-$15M biotech positions.

Cyclicals and Industrials: The Airlines Triple Play

A new cyclical sleeve appeared in Q4 with three airlines: Delta (DAL) at $45M, United (UAL) at $39M, and American Airlines (AAL) at $10M — totaling $94M. This is a direct bet on US domestic travel demand sustaining above pre-COVID levels while fuel costs moderate.

The industrial exposure is broader than airlines:

• Woodward (WWD): $179M (4.0%) — aerospace and defense industrial components. Duquesne's 8th-largest position.
• Alcoa (AA): $73M (1.6%) — aluminum producer, direct commodity cycle exposure.
• Wabtec (WAB): $64M (1.4%) — rail technology platform, infrastructure spending beneficiary.
• Bloom Energy (BE): $64M (1.4%) — clean energy fuel cells for data centers and distributed power.
• Cleveland-Cliffs (CLF): $23M — US steel production, reshoring theme.
• Southern Copper (SCCO): $17M — copper mining, electrification and AI datacenter build.

Combined with CRH Plc ($59M, construction materials) and Argan ($9M, power plant construction), the industrials and cyclicals cluster totals approximately $630M (~14% of portfolio). Druckenmiller is positioned for a world where physical infrastructure spend remains elevated — whether driven by reshoring, energy transition, or AI datacenter buildout.

Emerging Markets: A Broader International Bet

• Coupang (CPNG): $160M (3.6%) — South Korea's dominant e-commerce player.
• Sea Ltd (SE): $120M (2.7%) — Southeast Asia's e-commerce, gaming, and fintech platform.
• Taiwan Semiconductor (TSM): $165M (3.7%) — the foundational AI semiconductor bet, held across quarters.
• iShares MSCI Emerging Markets (EEM): $49M (1.1%) — broad EM basket complement.

Total non-US equity exposure exceeds $780M (~17% of portfolio). For a fund that historically concentrated in US growth stocks, this is a meaningful diversification signal. It mirrors the broader institutional rotation we tracked in our Q4 2025 institutional consensus report.

AUM Trajectory: The Recovery Story

Duquesne's AUM journey since 2021 tells a macro story in itself. The fund peaked at $3.89B in Q1 2021, cratered to $1.38B in Q2 2022 (the bear market trough where Druckenmiller cut exposure aggressively), then steadily rebuilt. The Q4 2025 reading of $4.49B represents a 225% recovery from that trough and a new post-2021 high.

The volatility is the point. Druckenmiller's turnover rate of 43.1% in Q4 — and an even higher 92.3% in Q3 — reflects his core philosophy: “The way to build long-term returns is through preservation of capital and home runs.” He cuts fast, sizes aggressively, and the AUM trajectory is the scoreboard.

What Analysts Might Misread

1. “Druckenmiller abandoned tech.” No. He abandoned crowded tech. GOOGL (+277%) and AMZN (+69% with calls) are significant increases. The exits (META, ARM, Sandisk) were in names where consensus positioning caught up to the trade.
2. “The EWZ position is a short-term trade.” Maybe — Druckenmiller's 43% turnover rate means nothing stays forever. But the call options and the structural thesis (Selic cuts + commodity cycle + weak USD) suggest this is a position he sized for a multi-quarter move, not a rental.

Q&A

What did Druckenmiller buy in Q4 2025?

The largest new positions were XLF ($301M), EWZ ($247M with calls), and RSP ($225M). He also initiated positions in Goldman Sachs, Delta Air Lines, United Airlines, Alcoa, and Cleveland-Cliffs. See the full holdings on Duquesne's filer page.

Did Druckenmiller sell Meta in Q4 2025?

Yes. Druckenmiller completely exited his Meta Platforms position after holding it for only one quarter (initiated in Q3 2025). He also exited ARM Holdings, Sandisk, and Seagate Technology.

What is Druckenmiller's biggest position in Q4 2025?

Natera (NTRA) remains the #1 holding at $575M (12.8% of portfolio), followed by XLF ($301M), Insmed ($258M), and EWZ ($247M).

Why did Druckenmiller invest in Brazil?

Druckenmiller built a $247M EWZ position with leveraged call options, betting on three catalysts: Brazil's Selic rate cutting cycle, commodity supercycle benefits (oil, iron ore, soybeans), and a weakening US dollar lifting EM returns. The trade has gained 19% YTD as R$33B of foreign capital entered Brazil's B3 exchange in January 2026.

Is Druckenmiller still invested in Teva?

Yes. Teva (TEVA) remains in the portfolio at $183M (4.1%), ranked #7. However, its weight fell from ~8.4% in Q3 as the new macro ETF positions diluted healthcare concentration.

How much did Duquesne's AUM change in Q4 2025?

Duquesne's 13F-reported AUM grew from $4.06B to $4.49B, a +$432M increase (+10.6%). This is the highest level since Q1 2024 ($4.39B) and reflects both new capital deployment and portfolio appreciation.